Analysis of the N-acetyltransferase 2 gene polymorphism in the patients with chronic obstructive pulmonary disease and in populations of the Volga-Ural region

被引:1
作者
Viktorova, TV [1 ]
Koritina, GF [1 ]
Makarova, OV [1 ]
Yanbaeva, DG [1 ]
Yakupova, EV [1 ]
Khusnutdinova, EK [1 ]
机构
[1] Russian Acad Sci, Inst Biochem, Ufa 450054, Bashkortostan, Russia
关键词
D O I
10.1023/A:1024426431050
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Restriction fragment-length polymorphism of the gene coding for N-acetyltransferase 2 (NAT2) was typed in populations of the Volga-Ural region (Bashkirs, Tatars, Chuvashes, Udmurts, and Russians) as well as in patients with chronic obstructive pulmonary disease (COPD) and in healthy individuals. Rapid and slow acetylator phenotypes were determined based on the presence or absence of the KpnI, TaqI, and BamHI restriction endonuclease recognition sites. The proportion of slow acetylators in the populations examined varied from 40.00% in Bashkirs to 64.15% in Chuvashes with statistically significant difference between these two ethnic groups (chi(2)=5.7; P=0.02). Overall, in the Volga-Ural populations slow acetylators represented 56.25% of the subjects examined. This value was similar to those presented in other studies of Caucasoid populations. In the COPD patients a statistically significant decrease of the slow acetylator frequency to 48.28% compared to healthy individuals (62.18%) was observed (chi(2)=4.60; P=0.036). The data obtained suggest a possible association between the drug resistance in the COPD patients with the rapid acetylator phenotype, which can lead to the development of the chronic form of the disease.
引用
收藏
页码:712 / 714
页数:3
相关论文
共 15 条
  • [1] BARANOV VS, 2000, GENOM CHELOVEKA ENY
  • [2] Diversity of mitochondrial DNA haplogroups in ethnic populations of the Volga-Ural region
    Bermisheva, MA
    Tambets, K
    Villems, R
    Khusnutdinova, EK
    [J]. MOLECULAR BIOLOGY, 2002, 36 (06) : 802 - 812
  • [3] Chen J, 1998, CANCER RES, V58, P3307
  • [4] EVANS DAP, 1993, GENETIC FACTORS DRUG
  • [5] Khusnutdinova E. K., 1999, Genetika, V35, P1132
  • [6] Krajinovic M, 2000, CANCER EPIDEM BIOMAR, V9, P557
  • [7] Kulinskii V.I., 1999, SOROS OBRAZOVAT ZH, V1, P8
  • [8] Lyakhovich V. V., 2000, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P36
  • [9] Molecular mechanisms of genetic polymorphisms of drug metabolism
    Meyer, UA
    Zanger, UM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 269 - 296
  • [10] Nebert DW, 1997, AM J HUM GENET, V60, P265